{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:41:55Z","timestamp":1785660115093,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","award":["2019\/13316 HEIDIFEC"],"award-info":[{"award-number":["2019\/13316 HEIDIFEC"]}],"id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multimorbidity and prolonged use of addictive medications are prevalent among older patients, and known to increase the risk of adverse drug events. Yet, the relationship between these two entities has remained understudied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>This study explored the association between multimorbidity burden and prolonged use of addictive medications in geriatric patients, adjusted for clinically important covariates. Furthermore, we identified comorbidity patterns in prolonged users.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a cross-sectional study on a consecutive sample of 246 patients, aged 65\u201390\u00a0years, admitted to a large public university hospital in Norway. We defined prolonged use of addictive medications as using benzodiazepines, opioids and\/or z-hypnotics beyond the duration recommended by clinical guidelines (\u2265\u20094\u00a0weeks). Multimorbidity was assessed with the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), based on diagnoses made by independent physicians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to non-prolonged use, prolonged use was significantly more common among patients who had psychiatric (19\/27, 70%), liver (19\/22, 86%), upper gastrointestinal tract (21\/32, 66%), musculoskeletal (52\/96, 54%), or nervous system disorders (46\/92, 50%). Patients with prolonged use had a higher multimorbidity burden than those without such use (CIRS-G score, mean\u2009=\u20097.7, SD\u2009=\u20092.7 versus mean\u2009=\u20094.6, SD\u2009=\u20092.2, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Multivariable logistic regression indicated a significant association between multimorbidity burden and prolonged addictive medication use (OR\u2009=\u20091.72, 95% CI 1.42\u20132.08). Predictive margins postestimation showed a systematic increase in the predicted CIRS-G scores when the number of addictive drug used increases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Multimorbidity is strongly associated with prolonged use of addictive medications. Multiple substance use may aggravate disease burden of older patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40520-021-01791-5","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T06:33:15Z","timestamp":1613716395000},"page":"2857-2864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The patterns and burden of multimorbidity in geriatric patients with prolonged use of addictive medications"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-7585","authenticated-orcid":false,"given":"Socheat","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahreem Ghazal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen Saxhaug","family":"Kristoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christofer","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"issue":"1","key":"1791_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-017-0068-3","volume":"6","author":"JV Pergolizzi","year":"2017","unstructured":"Pergolizzi JV, LeQuang JA, Berger GK et al (2017) The basic pharmacology of opioids informs the opioid discourse about misuse and abuse: a review. Pain Therapy 6:1\u201316","journal-title":"Pain Therapy"},{"key":"1791_CR2","doi-asserted-by":"crossref","unstructured":"Batlle E, Lizano E, Vi\u00f1as M, et al (2019) 1, 4-Benzodiazepines and new derivatives: description, analysis, and organic synthesis. In: Janka V, Ladislav V (eds) Medicinal chemistry,  pp 63\u201390","DOI":"10.5772\/intechopen.79879"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.archger.2016.09.003","volume":"68","author":"G Lucchetti","year":"2017","unstructured":"Lucchetti G, Lucchetti AL (2017) Inappropriate prescribing in older persons: a systematic review of medications available in different criteria. Arch Gerontol Geriatr 68:55\u201361","journal-title":"Arch Gerontol Geriatr"},{"key":"1791_CR4","volume-title":"Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice","author":"C Ford","year":"2014","unstructured":"Ford C, Law F, Barjolin J et al (2014) Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice. SMMGP, London"},{"issue":"2","key":"1791_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/15360288.2016.1173761","volume":"30","author":"Centers for Disease C, Prevention PHSUSDoH, Human S","year":"2016","unstructured":"Centers for Disease C, Prevention PHSUSDoH, Human S (2016) Guideline for Prescribing Opioids for Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy 30:138\u2013140","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy."},{"issue":"6","key":"1791_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/SLA.0000000000002461","volume":"268","author":"R Daoust","year":"2018","unstructured":"Daoust R, Paquet J, Moore L et al (2018) Incidence and risk factors of long-term opioid use in elderly trauma patients. Ann Surg 268:985\u2013991","journal-title":"Ann Surg."},{"issue":"6\u20137","key":"1791_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/2045125317696454","volume":"7","author":"L Jacob","year":"2017","unstructured":"Jacob L, Rapp MA, Kostev K (2017) Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Therap Adv Psychopharmacol 7:191\u2013200","journal-title":"Therap Adv Psychopharmacol"},{"issue":"2","key":"1791_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/02813432.2018.1459164","volume":"36","author":"AC Sundseth","year":"2018","unstructured":"Sundseth AC, Gjelstad S, Straand J et al (2018) General practitioners\u2019 prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study. Scand J Primary Health Care 36:115\u2013122","journal-title":"Scand J Primary Health Care."},{"issue":"3","key":"1791_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/bcpt.12684","volume":"120","author":"S Sakshaug","year":"2017","unstructured":"Sakshaug S, Handal M, Hjellvik V et al (2017) Long-term use of Z-hypnotics and co-medication with benzodiazepines and opioids. Basic Clin Pharmacol Toxicol 120:292\u2013298","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"1791_CR10","doi-asserted-by":"publisher","first-page":"e031483","DOI":"10.1136\/bmjopen-2019-031483","volume":"9","author":"S Cheng","year":"2019","unstructured":"Cheng S, Siddiqui TG, Gossop M, Kristoffersen ES, Lundqvist C (2019) Sociodemographic, clinical and pharmacological profiles of medication misuse and dependence in hospitalised older patients in Norway: a prospective cross-sectional study. BMJ open 9:e031483","journal-title":"BMJ open"},{"issue":"5","key":"1791_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/gerona\/gly110","volume":"74","author":"DL Vetrano","year":"2018","unstructured":"Vetrano DL, Palmer K, Marengoni A et al (2018) Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol Ser A 74:659\u2013666","journal-title":"J of Gerontol Ser A"},{"issue":"4","key":"1791_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM (2014) Ageing and the epidemiology of multimorbidity. European Respiratory Journal 44(4):1063\u20131064","journal-title":"European Respiratory Journal"},{"issue":"1","key":"1791_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12955-019-1180-3","volume":"17","author":"S Pati","year":"2019","unstructured":"Pati S, Swain S, Knottnerus JA et al (2019) Health related quality of life in multimorbidity: a primary-care based study from Odisha, India. Health Qual Life Outcomes 17:116","journal-title":"Health Qual Life Outcomes."},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12875-015-0344-4","volume":"16","author":"K Moffat","year":"2015","unstructured":"Moffat K, Mercer SW (2015) Challenges of managing people with multimorbidity in today\u2019s healthcare systems. BMC Fam Pract 16:129","journal-title":"BMC Fam Pract."},{"issue":"4","key":"1791_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/jpm.2019.0260","volume":"23","author":"S Schear","year":"2020","unstructured":"Schear S, Patel K, Deng LX et al (2020) Multimorbidity and opioid prescribing in hospitalized older adults. J Palliat Med 23:475\u2013482","journal-title":"J Palliat Med"},{"issue":"1","key":"1791_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12875-019-0969-9","volume":"20","author":"M Guisado-Clavero","year":"2019","unstructured":"Guisado-Clavero M, Viol\u00e1n C, L\u00f3pez-Jimenez T et al (2019) Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients. BMC Fam Pract 20:82","journal-title":"BMC Fam Pract."},{"issue":"1","key":"1791_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000109763","volume":"16","author":"J Karlawish","year":"2008","unstructured":"Karlawish J (2008) Measuring decision-making capacity in cognitively impaired individuals. Neuro-Signals 16:91\u201398","journal-title":"Neuro-Signals"},{"issue":"3","key":"1791_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","volume":"41","author":"MD Miller","year":"1992","unstructured":"Miller MD, Paradis CF, Houck PR et al (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237\u2013248","journal-title":"Psychiatry Res"},{"issue":"12","key":"1791_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1553-2712.2001.tb01132.x","volume":"8","author":"PE Bijur","year":"2001","unstructured":"Bijur PE, Silver W, Gallagher EJ (2001) Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 8:1153\u20131157","journal-title":"Acad Emerg Med"},{"issue":"6","key":"1791_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1791_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13104-016-2284-z","volume":"9","author":"ML Bell","year":"2016","unstructured":"Bell ML, Fairclough DL, Fiero MH et al (2016) Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Res Notes 9:479","journal-title":"BMC Res Notes"},{"issue":"1","key":"1791_CR22","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.9778\/cmajo.20160056","volume":"5","author":"D Weymann","year":"2017","unstructured":"Weymann D, Gladstone EJ, Smolina K et al (2017) Long-term sedative use among community-dwelling adults: a population-based analysis. CMAJ Open 5:E52\u2013E60","journal-title":"CMAJ Open"},{"issue":"1","key":"1791_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40360-017-0149-2","volume":"18","author":"P-J Samuelsen","year":"2017","unstructured":"Samuelsen P-J, Nielsen CS, Wilsgaard T et al (2017) Pain sensitivity and analgesic use among 10,486 adults: the Troms\u00f8 study. BMC Pharmacol Toxicol 18:45","journal-title":"BMC Pharmacol Toxicol."},{"issue":"1","key":"1791_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12875-016-0469-0","volume":"17","author":"K Linnet","year":"2016","unstructured":"Linnet K, Gudmundsson LS, Birgisdottir FG et al (2016) Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. BMC Fam Pract 17:69","journal-title":"BMC Fam Pract"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"h176","DOI":"10.1136\/bmj.h176","volume":"350","author":"E Wallace","year":"2015","unstructured":"Wallace E, Salisbury C, Guthrie B et al (2015) Managing patients with multimorbidity in primary care. BMJ 350:h176","journal-title":"BMJ"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/JPR.S138698","volume":"10","author":"X-Q Feng","year":"2017","unstructured":"Feng X-Q, Zhu L-I, Zhou Q (2017) Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res 10:1225","journal-title":"J Pain Res."},{"key":"1791_CR27","doi-asserted-by":"publisher","unstructured":"Moody DE (2012) Drug interactions with benzodiazepines: epidemiologic correlates with other CNS depressants and in vitro correlates with inhibitors and inducers of cytochrome P450 3A4. In: Mozayani A, Raymon L (eds) Handbook of Drug Interactions: A Clinical and Forensic Guide. Humana Press, Totowa, NJ, pp 25\u2013116. https:\/\/doi.org\/10.1007\/978-1-61779-222-9_2","DOI":"10.1007\/978-1-61779-222-9_2"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"i4843","DOI":"10.1136\/bmj.i4843","volume":"354","author":"C Farmer","year":"2016","unstructured":"Farmer C, Fenu E, O\u2019Flynn N et al (2016) Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ 354:i4843","journal-title":"BMJ"},{"issue":"15","key":"1791_CR29","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA 315:1624\u20131645","journal-title":"JAMA"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-021-01791-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T04:42:58Z","timestamp":1634791378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-021-01791-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s40520-021-01791-5","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"25 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that no relevant conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was granted ethical approval by the Regional Committee for Medical Research Ethics (2016\/2289\/REK S\u00f8r-\u00d8st) and the Data Protection Officer at the study setting (17\u2013054).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}}]}}